This is an educational tool — it is not a prediction of future returns and should not be interpreted as investment advice. Methodology · Terms of Service →

EXELExelixis, Inc.

stock · Healthcare

Factor Scores

BalancedStrong

+63.8%

Confidence: HIGH

ValueStrong

+58.2%

Confidence: HIGH

GrowthStrong

+45.2%

Confidence: HIGH

QualityStrong

+65.3%

Confidence: HIGH

GARPStrong

+52.2%

Confidence: HIGH

MomentumStrong

+56.0%

Confidence: HIGH

Analysis Notes

•At the current price, the model estimates approximately 6.6% annual earnings growth is priced in over 10 years (assuming a 10% discount rate). The 3-year trailing EDGAR EPS CAGR is 70.4% — the implied rate is 63.8pp below the historical trajectory.